Stock prices for Novo Nordisk dropped precipitously Friday after a last-minute announcement from the Biden administration ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock to "buy" from "neutral," calling the recent sell-off of the stock "overdone.

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

The country's GDP expanded by 2% over the final three months of 2023, according to official figures, and posted growth of 1.8% for last year ... drugs has sent its stock price skyrocketing ...

The company's weight-loss drugs have been shown to be more effective than rival Ozempic ... the stock trades at a forward price-to-earnings (P/E) ratio of 35 times next year's analyst estimates ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both ... to win expanded insurance coverage for Wegovy. Last year, Wegovy won approval in the U.S. for use ...

including Ozempic and Wegovy — the blockbuster diabetes and weight loss drugs. The drugs have faced public backlash over their high price, fueling demand for cheaper alternatives. The list, which ...